Home » Topics » Regulatory

Regulatory
RSS

Controlled-release tramadol under development

Jan. 20, 1998

Sheffield proceeds with development of respiratory drugs in its MSI

Jan. 20, 1998

Zeneca commits to development of Zomig line extensions

Jan. 20, 1998

Lovenox/Clexane receives approvals in 11 additional countries

Jan. 20, 1998

Cardizem Monovial now available in U.S.

Jan. 19, 1998

Paxene tentatively approved by FDA

Jan. 16, 1998

Connetics to develop clobetasol mousse for dermatoses

Jan. 16, 1998

FDA clears new indication for Rythmol

Jan. 15, 1998

FDA approves first OTC drug for migraine

Jan. 15, 1998

Pivotal trial of PROSORBA column in RA stopped early due to favorable results

Jan. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...